Draganfly Announces Closing of US$50.0 Million Registered Direct Offering

Executive Summary

• Draganfly Inc. closed a registered direct offering of 7,150,000 common shares (or pre‑funded warrants) at US $7.00 per share, generating approximately US $50.0 million in gross proceeds.
• Net proceeds are earmarked for general corporate purposes, including funding growth initiatives, working capital, product development, potential acquisitions, and R&D.
• The offering was conducted under an effective shelf registration statement (Form F‑10) and a Canadian short‑form base shelf prospectus; securities were sold only to U.S. investors.

Key Details

• Offering Size: 7,150,000 common shares (or pre‑funded warrants).
• Price per Share/Warrant: US $7.00.
• Gross Proceeds: Approximately US $50.0 million (before placement agent discounts and offering expenses).
• Placement Agents: Lead – Maxim Group LLC; Co‑placement – Raymond James Ltd. and Ladenburg Thalmann & Co. Inc.
• Use of Net Proceeds: General corporate purposes, including:
• Funding capabilities to meet demand for new products.
• Growth initiatives and working capital requirements.
• Continuing development and marketing of core products.
• Potential acquisitions.
• Research and development activities.
• Regulatory Filings:
• Effective shelf registration statement on Form F‑10 (File No. 333‑290823) automatically effective February 25, 2026.
• Canadian short‑form base shelf prospectus dated October 24, 2025.
• Geographic Scope of Offering: Securities offered and sold in the United States only; no Canadian purchasers participated.
• Prospectus Availability: Filed with securities commissions in British Columbia, Saskatchewan, Ontario, and with the SEC; accessible via SEDAR+ (www.sedarplus.ca) and SEC website (www.sec.gov).

Notable Quotes

(No executive quotes were included in the release.)